You are here

  • Home
  • Archive
  • Volume 9, Issue 4
  • Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Original research
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis

Authors

  • Joakim Lindqvist Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, SwedenMedical Unit of Gastroenterology, Dermatology and Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Johan Askling Medical Unit of Gastroenterology, Dermatology and Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, SwedenClinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Jon Lampa Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, SwedenMedical Unit of Gastroenterology, Dermatology and Rheumatology, Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Joakim Lindqvist; joakim.lindqvist{at}ki.se
View Full Text

Citation

Lindqvist J, Askling J, Lampa J
Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis
RMD Open 2023;9:e003111. doi: 10.1136/rmdopen-2023-003111

Publication history

  • Received May 18, 2023
  • Accepted October 9, 2023
  • First published November 16, 2023.
Online issue publication 
November 16, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.